Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 6 min ago
Peer-reviewedCC BY 4.0Frontiers in Cardiovascular Medicine

Hybrid near-infrared spectroscopy–intravascular ultrasound imaging: integrating plaque biology, procedural precision, and prognostic stratification in contemporary coronary intervention

6 affiliations
  1. 18th Department of Cardiology, Hygeia Hospital
  2. 2Second Department of Cardiology, Attikon University Hospital, National and Kapodistrian University of Athens
  3. 3Department of Cardiology, St Thomas' Hospital, Guy's and St Thomas' NHS Foundation Trust
  4. 4CT and MRI Department, Hygeia Hospital
  5. 5Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust
  6. 6William Harvey Research Institute, Queen Mary University of London

Abstract

Hybrid near-infrared spectroscopy-intravascular ultrasound (NIRS/IVUS) represents a major advancement in intracoronary imaging as it combines an ultra-high-resolution ultrasound image processing of the vessel lumen and atherosclerotic plaque with an automated algorithm for the detection and quantification of the plaque lipid-core. This unique feature allows for a detailed biologic assessment of the plaque composition and quantification beyond the conventional angiographic estimation of coronary artery stenosis severity. High lipidic atherosclerotic burden, as this is predominantly defined by maxLCBI 4mm ≥400, identifies high-risk vulnerable plaques and independently predicts future non-culprit major cardiovascular events and a higher risk of periprocedural myocardial injury during percutaneous coronary intervention (PCI). Segments with maxLCBI 4mm >400 carry a 3- to 4-fold higher risk of non-culprit events (LRP), and lesions combining plaque burden ≥70% with maxLCBI 4mm ≥324.7 have a 7% 4-year event rate (PROSPECT II). Emerging evidence from the PREVENT trial suggests that preventive PCI of imaging-defined vulnerable plaques may reduce future events, although this benefit was driven predominantly by ischaemia-driven revascularization and hospitalization rather than by reductions in death or myocardial infarction. This strategy therefore remains investigational, and it is not yet incorporated into major guideline recommendations. NIRS-IVUS has additionally been used to demonstrate the prognostic value of lipid reduction after successful PCI. In this review, we provide a mechanistic synthesis of key randomized trials (PROSPECT II, LRP, and PREVENT) and observational registries to summarize contemporary evidence for the use of NIRS/IVUS in cardiovascular risk stratification, vulnerable-plaque detection, and PCI optimization, including the potential prognostic implications of post-PCI residual lipid burden. We also present case examples and a proposed, investigational algorithm for integrating the NIRS/IVUS system into lesion-level clinical decision-making.

Related

  1. Metabolic and Renal Dysfunction Are Associated With Intraplaque Lipid Burden Assessed by Near‐Infrared Spectroscopy Intravascular Ultrasound: Insights Into the Cardiovascular–Kidney–Metabolic Axis
    Hyungdon Kook, Woohyeun Kim, Seong Rae Cho +1
    Journal of the American Heart AssociationPeer-reviewedLicence not statedCardiovascular medicineCrossref
  2. Ultra-low contrast intravascular ultrasound-guided percutaneous coronary intervention of the left main and left anterior descending artery in advanced chronic kidney disease
    Grzegorz Jodlowski, Dawid Ilnicki, Lukasz Osuch +3
    Postepy w kardiologii interwencyjnej = Advances in interventional cardiologyPeer-reviewedCC BY-NC-SAFull textSurgery & anaesthesiaEurope PMCPMC
  3. Cytomegalovirus Retinitis Across the Immunosuppression Spectrum: A Contemporary Framework for Risk Stratification, Diagnosis, and Vision-Preserving Therapy
    Journal of clinical medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Clinically Accessible Phenotypes Refine Cardiovascular Risk Stratification Beyond Contemporary Clinical Equations
    H. Yang, J. Guo, X. Shi +6
    medRxivPreprintAll rights reservedFull textEpidemiology & public healthmedRxiv
  5. Beyond Angiography: Integrating Intravascular Imaging and Physiology to Step up to Modern PCI
    Vincenzo Paragliola, Federico Moretti, Andrea Moretti +2
    Journal of Clinical MedicinePeer-reviewedCC BY 4.0General medicineCrossref
BibTeX
@article{xenogiannis2026hybrid,
  title = {{Hybrid near-infrared spectroscopy–intravascular ultrasound imaging: integrating plaque biology, procedural precision, and prognostic stratification in contemporary coronary intervention}},
  author = {Iosif Xenogiannis and Andreas S. Triantafyllis and Grigoris V. Karamasis and Antonis N. Pavlidis and Christos Mourmouris and Christos V. Bourantas and Andreas S. Kalogeropoulos},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2026},
  month = nov,
  doi = {10.3389/fcvm.2026.1882812},
  url = {https://www.frontiersin.org/articles/10.3389/fcvm.2026.1882812/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Hybrid near-infrared spectroscopy–intravascular ultrasound imaging: integrating plaque biology, procedural precision, and prognostic stratification in contemporary coronary intervention
AU  - Iosif Xenogiannis
AU  - Andreas S. Triantafyllis
AU  - Grigoris V. Karamasis
AU  - Antonis N. Pavlidis
AU  - Christos Mourmouris
AU  - Christos V. Bourantas
AU  - Andreas S. Kalogeropoulos
PY  - 2026
DA  - 2026/11/12
JO  - Frontiers in Cardiovascular Medicine
DO  - 10.3389/fcvm.2026.1882812
UR  - https://www.frontiersin.org/articles/10.3389/fcvm.2026.1882812/full
AB  - Hybrid near-infrared spectroscopy-intravascular ultrasound (NIRS/IVUS) represents a major advancement in intracoronary imaging as it combines an ultra-high-resolution ultrasound image processing of the vessel lumen and atherosclerotic plaque with an automated algorithm for the detection and quantification of the plaque lipid-core. This unique feature allows for a detailed biologic assessment of the plaque composition and quantification beyond the conventional angiographic estimation of coronary artery stenosis severity. High lipidic atherosclerotic burden, as this is predominantly defined by maxLCBI 4mm ≥400, identifies high-risk vulnerable plaques and independently predicts future non-culprit major cardiovascular events and a higher risk of periprocedural myocardial injury during percutaneous coronary intervention (PCI). Segments with maxLCBI 4mm >400 carry a 3- to 4-fold higher risk of non-culprit events (LRP), and lesions combining plaque burden ≥70% with maxLCBI 4mm ≥324.7 have a 7% 4-year event rate (PROSPECT II). Emerging evidence from the PREVENT trial suggests that preventive PCI of imaging-defined vulnerable plaques may reduce future events, although this benefit was driven predominantly by ischaemia-driven revascularization and hospitalization rather than by reductions in death or myocardial infarction. This strategy therefore remains investigational, and it is not yet incorporated into major guideline recommendations. NIRS-IVUS has additionally been used to demonstrate the prognostic value of lipid reduction after successful PCI. In this review, we provide a mechanistic synthesis of key randomized trials (PROSPECT II, LRP, and PREVENT) and observational registries to summarize contemporary evidence for the use of NIRS/IVUS in cardiovascular risk stratification, vulnerable-plaque detection, and PCI optimization, including the potential prognostic implications of post-PCI residual lipid burden. We also present case examples and a proposed, investigational algorithm for integrating the NIRS/IVUS system into lesion-level clinical decision-making.
SN  - 2297-055X
ER  -